Back to School: How biopharma can reboot drug development. Access exclusive analysis here

New FDA rule on clinical trial subjects

The FDA announced today that it is amending regulations governing INDs to permit the agency to place a clinical hold on one or more studies under an IND "if men or

Read the full 315 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers